Notably, according to Horiguchi et al. (Horiguchi et al., 2008), if STAT3 activation is localized within hepatocytes, suppression of STAT3 activation should have resulted in greater hepatic steatosis, and higher serum and hepatic TG levels. This evidence concerns the gene STAT3 and Hepatic steatosis.